Medicine prices in Pakistan have recorded a sharp and unusual increase. The latest data was shared by the Drug Regulatory Authority of Pakistan (DRAP).
According to officials, several commonly used medicine brands have become significantly more expensive. The increase has raised serious concerns among patients and healthcare experts.
DRAP officials revealed that some medicine prices have increased by more than 180 percent. In extreme cases, the rise has crossed 1600 percent.
One of the biggest jumps was seen in Coldrex. This widely used flu medicine increased by 1621 percent. Its price rose from Rs27 to Rs475 per packet.
Another important medicine, Kalv, used for bone health, became 302 percent more expensive. This has affected regular patients relying on long-term treatment.
The painkiller Ibuprofen also saw a major rise. Its price increased by more than 244 percent in the local market.
Eye treatment medicine Polyflex increased from Rs34 to Rs113. This shows a steady upward trend in essential medicine costs.
Librex, used for stomach and intestinal issues, recorded a 241 percent increase. This has added pressure on patients with digestive disorders.
Other increases include Avil, an allergy injection, which rose from Rs432 to Rs1,500. Laxoberon, a constipation medicine, also became 200 percent more expensive.
The nausea and dizziness medicine Stimital increased by 188 percent. This has further impacted affordable treatment options.
Officials said rising medicine prices are becoming a major concern for public health. Many patients are struggling to afford basic treatment.
Health Minister Mustafa Kamal commented on the situation. He said the government has no financial link with pharmaceutical companies.
He also stressed that regulatory bodies remain independent in decision-making.
The sudden rise in medicine prices has caused public concern. Many citizens fear reduced access to essential healthcare.
Experts believe inflation and global supply issues may be contributing factors. However, they say stronger regulation is needed to control medicine costs.
In other related news also read Pakistan Sees Sharp Increase in Medicine Prices as DRAP Reveals Surge
Authorities are expected to review pricing policies soon. The goal is to ensure affordable medicine remains available for all patients across Pakistan..
